| Literature DB >> 26768664 |
L Tian1, S-C Choi1, H-N Lee1, Y Murakami1, C-F Qi2, M Sengottuvelu1, O Voss1, K Krzewski1, J E Coligan1.
Abstract
Homeostasis requires the immunologically silent clearance of apoptotic cells before they become pro-inflammatory necrotic cells. CD300f (CLM-1) is a phosphatidylserine receptor known to positively regulate efferocytosis by macrophages, and CD300f gene-deficient mice are predisposed to develop a lupus-like disease. Here we show that, in contrast to CD300f function in macrophages, its expression inhibits efferocytosis by DC, and its deficiency leads to enhanced antigen processing and T-cell priming by these DC. The consequences are the expansion of memory T cells and increased ANA levels in aged CD300f-deficient mice, which predispose CD300f-deficient mice to develop an overt autoimmune disease when exposed to an overload of apoptotic cells, or an exacerbated autoimmunity when combined with FcγRIIB deficiency. Thus, our data demonstrates that CD300f helps to maintain immune homeostasis by promoting macrophage clearance of self-antigens, while conversely inhibiting DC uptake and presentation of self-antigens.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26768664 PMCID: PMC4987725 DOI: 10.1038/cdd.2015.161
Source DB: PubMed Journal: Cell Death Differ ISSN: 1350-9047 Impact factor: 15.828